Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2024 May 14;4(5):e0003183. doi: 10.1371/journal.pgph.0003183

Integration of cervical cancer screening into healthcare facilities in low- and middle-income countries: A scoping review

Rahel Nega Kassa 1,2,*, Desalegn Markos Shifti 3, Kassahun Alemu 4, Akinyinka O Omigbodun 5
Editor: Sadeep Shrestha6
PMCID: PMC11093339  PMID: 38743652

Abstract

Cervical cancer is a prevalent disease among women, especially in low- and middle-income countries (LMICs), where most deaths occur. Integrating cervical cancer screening services into healthcare facilities is essential in combating the disease. Thus, this review aims to map evidence related to integrating cervical cancer screening into existing primary care services and identify associated barriers and facilitators in LMICs. The scoping review employed a five-step framework as proposed by Arksey and O’Malley. Five databases (MEDLINE, Maternity Infant Care, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science) were systematically searched. Data were extracted, charted, synthesized, and summarised. A total of 28 original articles conducted in LMICs from 2000 to 2023 were included. Thirty-nine percent of the reviewed studies showed that cervical cancer screening (CCS) was integrated into HIV clinics. The rest of the papers revealed that CCS was integrated into existing reproductive and sexual health clinics, maternal and child health, family planning, well-baby clinics, maternal health clinics, gynecology outpatient departments, and sexually transmitted infections clinics. The cost-effectiveness of integrated services, promotion, and international initiatives were identified as facilitators while resource scarcity, lack of skilled staff, high client loads, lack of preventive oncology policy, territorial disputes, and lack of national guidelines were identified as barriers to the services. The evidence suggests that CCS can be integrated into healthcare facilities in LMICs, in various primary care services, including HIV clinics, reproductive and sexual health clinics, well-baby clinics, maternal health clinics, and gynecology OPDs. However, barriers include limited health system capacity, workload, waiting times, and lack of coordination. Addressing these gaps could strengthen the successful integration of CCS into primary care services and improve cervical cancer prevention and treatment outcomes.

Introduction

Cervical cancer ranks as the fourth most prevalent cancer in women worldwide [1]. There were an estimated 604,127 new cervical cancer cases worldwide in 2020 and, the age-standardized incidence rates were highest in eastern Africa, followed by Southern Africa, and Middle Africa respectively [2]. In 2020, low- and middle-income countries (LMICs) accounted for about 90% of the projected 342,000 deaths from cervical cancer [2, 3].

Cervical cancer is preventable and curable, as long as it is detected early and managed effectively [4]. Quick and accurate CCS programs are critical so that every woman with cervical disease gets the treatment she needs, and avoidable deaths are prevented [5]. However, screening coverage of eligible women in most LMICs is on average 19%, compared to 63% in high-income countries [6]. A wide range of barriers, such as lack of knowledge and awareness of cervical cancer, cultural/traditional and religious factors, and health system barriers to screening, were identified across most LMICs [7].

The World Health Organization (WHO) recommends integrating CCS service into primary care packages at healthcare facilities as a solution [8] to overcome the burden related to cervical cancer in LMICs [9]. Therefore, the availability of integrated screening services in healthcare facilities can be used as an opportunity for those women who visit the facilities for different reasons to be screened and to achieve the 2030 cancer elimination goal (90-70-90 strategy) of the WHO. These are, 90% of women should get vaccinated, 70% of age-eligible women should get screened and 90% of women who have abnormalities detected should get treatment by 2030 [10]. Integrated service delivery leads to better quality of care, greater service provision, higher utilization of sexual and reproductive health services, more efficient use of resources, and better client satisfaction [1113].

Although several studies [1419] were conducted on CCS uptake among women in LMICs, there is still room for more comprehensive evidence on integration of CCS into healthcare facilities of LMICs. Therefore, the aim of this scoping review is, to summarize the existing evidence on the integration of CCS into healthcare facilities, and to identify barriers and facilitators associated with the integration of CCS programs into primary care in LMICs.

Methods

Review design

The protocol for this review has been published in BMJ Global Health Journal. The review was guided by the scoping review framework proposed by Arksey and O’Malley [20]. The framework consists of five steps such as 1) formulating the research questions, 2) identifying relevant studies, 3) selecting eligible studies, 4) charting the data, and 5) collating, summarising, and reporting the results as described below.

1. Formulating the research questions

Our research questions were developed and refined through an iterative process and consultations held by the multidisciplinary research team. The following questions were addressed by this scoping review: i) what is the existing evidence on the integration of cervical cancer screening programs into healthcare facilities in LMICs? and ii) what are the barriers and facilitators associated with the cervical cancer screening integration in healthcare facilities in LMICs?

2. Identifying relevant studies

The search strategy included terms that covered healthcare facilities, integration of cervical cancer screening, and LMICs (S1 Table). The search strategy was piloted to ensure the appropriateness of proposed keywords and databases. Peer-reviewed literature published were retrieved from the year 2000, which was a starting point for the implementation of the Millennium Development Goals (MDGs) that included achieving universal access to reproductive health by 2015 [21], till the year 2023.

A comprehensive literature search was conducted on the following five electronic databases: MEDLINE, Maternity Infant Care, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science. Manual searches of the articles’ reference lists were also conducted to identify additional potentially eligible studies not found in the databases.

3. Selecting eligible studies

Inclusion criteria

The eligibility criteria was set based on population, concepts, and contexts (PCC) framework described by JBI which was proposed by Peters et al. [22], shown in Table 1. Regarding the study type, we plan to include all primary studies published in a peer-reviewed journal that is accessible online and through interlibrary requests. Such studies could include randomized trials, observational studies, cross-sectional studies, case studies, and laboratory studies. Articles with non-English language and non-journal articles will be excluded.

Table 1. Inclusion criteria using the PCC framework.
Criteria Description
P-Population • Specialised Hospitals
• General Hospitals
• Primary Hospitals
• Central Hospitals
• Health Centres
• Clinics
• Primary care clinics
• Primary care services (MCH, HIV service, TB service, NCDs clinic, Outpatient clinic Reproductive health services, FP, routine genecology service)
C-Concept • Cervical cancer screening integration
• Barriers and facilitators of cervical cancer screening integration
C-Context Studies:
• Conducted in low and middle-income countries [23].
• Published from 2000 to 2023
• Written in English
• All primary studies
✓ Quantitative (cross-sectional/ observational),
✓ Qualitative (phenomenology, case study) and,
✓ Mixed-method published articles).

Screening

Eligibility screening was started by screening the title and abstracts of the included studies. All eligible articles were uploaded into Endnote 20 reference management software [24] and duplicates were identified and removed. Titles and abstracts screening and full-text reviews were done independently by two researchers [RNK and DMS] using Covidence software and checked the agreement of the included studies. A third reviewer [25] was employed to resolve the disagreement that were not resolved by discussion and consensus.

From April to September 2023, we conducted searches and independently evaluated the titles and abstracts of relevant publications using specific criteria for inclusion and exclusion. Records(n = 10,476) from the indexed articles were compiled, and duplicates were removed (n = 3,666). We screened records (n = 6,810) at the title and abstract screening level that resulted in (n = 120) articles that were screened for the full text review. Finally, 28 articles were included in the review process (Fig 1).

Fig 1. PRISMA-ScR flow chart illustrating the process of literature selection.

Fig 1

4. Charting the data

A spreadsheet of key factors was adapted and developed to extract relevant data from each included study [26, 27]. Two authors [RNK and DMS] tested and refined the data extraction tool using 10 eligible studies before its use. Reviewers extracted data from all eligible articles using the final form. The extracted data included key variables such as i) author(s) and year of publication, ii) country iii) study design iv) study period v) study setting, vi) study participants, vii) data collection methods, viii) key findings and ix) limitations of the study (Table 2).

Table 2. Summary of the articles.

Authors Country Study type/design Study period Study participants Study sample Study setting Data collection methods Limitations
Claey P et al. 2003 [45] Kenya Mixed design Nov1999 to Feb 2000 Women attending family planning clinics, health care professionals 981 Family Planning Association of Kenya (FPAK). Interviews and, a review of patient files ----------
Were E et al. 2010 [46] Kenya Cross-sectional May 2005 to Jan. 2006 Women 435 MTRH, MCH-FP clinic, and well-baby clinic in Teaching and Referral Hospital Face-to-face interviews ----------
Megan J et al.2015 [52] Kenya Cross-sectional Oct 2007 to Oct 2010 Health care providers, women aged less than 25 418 HIV care and treatment clinics at two hospitals Document review -----------
Smit et al. 2012 [47] South Africa Qualitative ----------- Policymakers, program managers, and academicians working in health policy 21 HIV clinic In-depth interview Risk of subjectivity
Odafe, S. et al. 2013 [53] Nigeria Cross-sectional Apr2010 to Apr2011 Women living with HIV 805 RH services clinic in district hospital EMR -----------
Padmaja R et al. 2013 [54] India Cross-sectional Two years Women aged 19 and above 350 (any clinic) in tertiary Hospital Specimen collection Small sample size
Chawla PC et al.2014 [51] India Cross-sectional Aug 2012 to Apr 2013 Public hospitals, Private Hospitals, and Primary health center (PHC) 312 Public hospitals, Private Hospitals and PHCs Standardized questionnaire -----------
Elizabeth Roger et al. 2014 [49] Haiti Qualitative/case report --------------- A 50-year-old female 1 Maternal Health Clinic Interview -----------
Kumakech et al. 2014 [38] Uganda Qualitative study Feb 2012 to Feb 2013 HCPs, Policymakers 16 Health facilities with HIV & CCS services clinics In-depth interview Small sample size, risk of response bias, risk of subjectivity
Anderson J et al.2015 [44] Côte d’Ivoire, Guyana, and Tanzania Cross-sectional Jan 2009 to Mar 2012 Women aged 30 to 50 years but not limited to HIV-positive women 3,4921 HIV clinics, RCH clinics in National hospitals, regional hospitals, District hospitals, and Health centres Data extraction from individual client records -----------
EL Sibanda et al. 2015 [37] Zimbabwe Qualitative Nov.2013 to Mar.2015 Women aged 18 to 52 69 Clinics providing integrated services In-depth interviewa ---------
Kumakech et al. 2015 [39] Uganda Qualitative study Feb. 2013 to Jan. 2014 Women and village health teams, husbands 24 3district hospitals FGDs and IDIs ---------
Shiferaw et al. 2016 [55] Ethiopia Cross-sectional Aug. 2010 to Mar. 2014 Women with HIV 16,632 HIV clinics in secondary and tertiary health facilities Document review Lack of generalizability
Bekolo CE et al.2016 [34] Cameroon Cross-sectional Feb and May 2014 Women aged 35 years and above attending HIV clinic 302 HIV clinic in a Regional Hospital Interview using a questionnaire ---------
Elisabeth L. Vodicka et al., 2017 [42] Kenya Cross-sectional July 1 to Oct 31, 2014 Women aged 18 and above, clinic staff 319 Child health clinic interviews ----------
Jenell S. et al. 2016 [56] Sub-Saharan African countries Cross-sectional Feb to Dec 2013 HIV clinics 78 HIV clinics Online interview, and patient record review. Sampling bias, low response rate, lack of representativeness
Katie A. Ports et al. 2015 [41] South Africa Mixed design --------------- Women aged 18 and above 79 Homeopathic clinic Face-to-face interview, IDIs ----------
Rupani, M. P., et al. 2017 [50] India Cross-sectional June 2011 to Oct. 2011 Reproductive age women 356 Gynecology OPD in tertiary care teaching hospital Interview Small sample size/lack of generalizability, response bias
Sam Phiri et al. 2016 [40] Malawi Cross-sectional Feb 2012 of May 2014 Reproductive age women 1495 FP and RH clinic Specimen collection ---------
Wendimagegn NF.2019 [57] Ethiopia Mixed design -------------- Women 296 Any clinic in hospitals and health centres Interview Lack of representativeness
Cecilia Milford et al, 2018 [58] South Africa Mixed design 2009 to 2011 Healthcare providers, senior management, professional nurses and doctors, counsellors 86 1 District hospital, 5 PHC, and one community health centre Focus group -----------
Colin Pfaf et al. 2018 [35] Malawi Cross-sectional May2016 to Mar.2017 Women aged 20 and above years 957 HIV clinic in Central Hospital/District Extracted from Electronic Medical Record [59], ----------
Boddu A et al. 2021 [60] India Cross-sectional Mar2014 to Feb2015 Women aged 30 to 59 404 HIV clinics Face-to-face Interview ----------
Mpata PC et al. 2021 [61] Zimbabwe Qualitative/ phenomenological Nov. 2017 to Feb. 2018 Women living with HIV 36 Opportunistic infection clinics in the hospitals IDI, FGDs -----------
Prisca C et al. 2021 [62] Kenya Mixed design June 2020 to Aug2020 Healthcare providers 79 20 PHC Face-to-face interview Small sample size, lack of generalizability, sampling error
Farida Selmouni et al. 2022 [48] Benin, Cote
d’Ivoire, and Senegal
Quantitative/observational May 2018 to Jan. 2021 Women aged 25–4 16,530 Primary health centres Performance checklist Sampling bias
Akpan, E et al. 2023 [63] Kenya Qualitative --------------- Nurses and managers ---------- Primary health facilities In-depth interview Lack of generalizability
Ninsiima et al. 2023 [25] Uganda Mixed design ----------- HIV-infected women 327 HIV clinic in Regional Referral Hospital in Mbarara District Face to face interview, FDGs Lack of generalizability

CCS: Cervical Cancer Screening; CHC: Child Health Clinic; EMR: Electronic Medical Record; FPAK: Family Planning Association of Kenya; FGD: Focus Group Discussion; IDI: In depth Interview; HCPs: Health care providers; HIV: Human Immunodeficiency Virus; PHC: Primary Health centre; MCH: Maternal & Child Health Clinic; MTRH: Maternal &Reproductive Health; OPD: Outpatient department; RCH: Reproductive & Child Health; RH: Reproductive Health

5. Collating, summarising, and reporting the results

Findings of the scoping review were presented using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA–ScR) guidelines [28]. A PRISMA flow diagram was used to demonstrate the literature study selection process and search results. A descriptive numerical summary was used to present the characteristics of the included studies while a qualitative thematic synthesis was conducted to narrate the findings. The results were classified under the main conceptual categories, such as “integration of cervical cancer screening” and “facilitators and barriers to the integration program”. Under each category, we further provided data on the article’s characteristics, including, but not limited to, the total number of studies, types of study design, sources of data, year of publication and key findings. Tables and figures were used to present the results in line with the aims of the scope of the review.

Quality assessment

Joanna Briggs Institute (JBI) quality appraisal tools [2933] were used to assess the methodological quality of the included articles by evaluating the extent to which they addressed the possibility of bias in areas of study design, conduct, and analysis (S2 Table). The magnitude of studies with a total score indicating poor quality was discussed among the researchers. Two researchers [RNK and DMS] independently assessed each included paper and any uncertainty regarding the quality of publications was resolved through discussion. Although a formal assessment of the methodological quality of the included studies was performed; articles with poor quality were not excluded.

Accordingly, we evaluated a total of 21 cross-sectional research articles and 7 qualitative research articles. Out of the 21 cross-sectional studies, only one achieved a perfect score of 8 out of 8. Five of the studies received a score of 6 out of 8, while 5 studies scored 5 out of 8. Two articles failed to identify and address confounding factors, while another three articles were unclear in their strategies for dealing with them. Additionally, three studies did not provide clear criteria for sample inclusion, and three studies did not properly state the validity and reliability of their exposure measurements.

Among the 7 qualitative research articles, 3 achieved a score of 8 out of 10, 2 received a score of 7 out of 10, and the remaining 2 scored 6 out of 10. Besides, all included articles drew their conclusions from data analysis or interpretation. Over half of the articles did not explicitly state the cultural and theoretical background of the researcher. Five articles did not address the influence of the researcher on the research, while four articles did not adequately represent the study participants and their perspectives.

Results

Characteristics of the reviewed articles

A total of 28 articles were summarized in this review (Table 2), which were obtained from indexed databases. These studies covered a range of low- and middle-income countries (LMICs), including Kenya, India, Uganda, South Africa, Ethiopia, Malawi, Zimbabwe, Benin, Cote d’ Ivoire, Senegal, Cameroon, Guyana, Tanzania, Nigeria, and other sub-Saharan African countries. Of the articles reviewed, over half (53.6%) were quantitative studies. In addition to these studies, there were also six articles with a mixed study design and seven articles with a qualitative research design. A significant portion (26.6%) utilized patient records and analysed data from health system repositories. As a result, the sample sizes of these studies varied widely, with a range from 1 participant to as many as 34,921, and a median sample size of 319.

The majority (57.1%) of the included studies were conducted in hospital settings, such as referral hospitals, regional hospitals, district hospitals, and one private hospital. Only six studies focused on primary healthcare settings. The studies covered a range of clinics, with the plurality (39%) focusing on HIV clinics. Others included child health clinics, maternal health clinics, family planning clinics, reproductive health clinics, integrated service clinics, opportunistic infection clinics, and homeopathic clinics. In most studies, CCS integration mainly occurred in HIV clinics [25, 3440]. A study conducted in South Africa showed that all key informants were in support of providing pap smears at HIV clinics because they saw a need for healthcare to be more comprehensive [41, 42].

However, some studies found that CCS was integrated into existing reproductive and sexual health [43] clinics, MCH-FP, well-baby clinics, maternal health clinics, Gynecology OPD, STD clinics and this was feasible in resource-poor settings [4450]. Therefore, with adequate infrastructural support, training, mentoring, and program supervision, cervical cancer screening and treatment services can be effectively provided opportunistically [48].

More than two-thirds (67.8%) of the studies included women aged 18 to 59 as study participants, whereas the other ones considered policy makers, senior management, healthcare providers, academicians working in health policy, counsellors, village health teams, and husbands. Two studies even utilized the health facilities themselves as study participants, specifically the HIV clinics and a combination of public hospitals, private hospitals, and primary care centres. The frequently used data collection methods were face-to-face interviews, focus group discussions and in-depth interviews.

Cervical cancer screening integration into the healthcare facilities in LMICs

Through this review, we identified ways of CCS integration into healthcare facilities and explored different facilitators and barriers to the integration of CCS, which are detailed in (Tables 3 and 4). The integration of CCS into the health care facilities was thematized into two groups: ways of integrating the CCS into the health care facilities, and benefits/acceptance of integrated CCS service.

Table 3. Key findings on the integration of CCS service into health facilities in LMICs.

Theme Conclusion
Ways/sites of Integrating the CCS into healthcare facilities
CCS integration mainly occurred in HIV clinics[25, 3442]. CCS was also integrated into existing reproductive and sexual health [43] clinics, MCH-FP, well-baby clinics, maternal health clinics, Gynecology OPD, STD clinics [4450, 53]. Integrated cervical cancer screening and treatment services can be effectively provided opportunistically and feasible in resource-poor settings [36, 48, 53, 54].
Acceptance of integration of CCS service into healthcare facilities
Most of the women who participated in the studies accepted cervical cancer screening integrated within HIV clinics, the MCH-FP clinics, and sexual and reproductive health [25, 40, 46, 53, 64]. Integration of cervical cancer screening and genital tract infection identification and treatment into the existing MCH-FP appears feasible [46].
Benefits of integration of CCS service into health care facilities
Comprehensive and convenient to access all services under one roof, facilitates early detection and treatment, minimizes loss to follow-up, cost-effective, and perceived benefits, and reduces patient visits [25, 37, 38, 4042, 45, 61]. CCS could be integrated into other existing healthcare services, such as routine immunizations and family planning programs, where women already engage with the healthcare system [38, 49].
Disadvantage of integrated CCS services
Increases the workload for healthcare providers, and fragmentation of services if the service is given in a separate room within the health facility [62]. Feeling empathy/emotional distress for testing positive for both HIV and cervical cancer lesions, decrease in the number of women screened per day, and feeling disrespectful or offensive to their needs due to the prolonged time [25, 37, 38, 45, 58].

Table 4. Key findings on facilitators and barriers of integrated cervical cancer screening service in LMICs.

Theme/ Level Facilitators Barriers Possible solutions
Individual/
Women-Level
Comprehensiveness of the services, accessibility of multiple services [37, 45]. Willingness to undergo screening [48]. Perceived risk, support from peers, perceived risk, availability of free services, and increased spread of information [37]. Cost-saving approach [42]. Difficulties in persuading women, and reluctance to visit another clinic if the integration is in a separate clinic. Economic constraints and lack of social support, long waiting times [25, 45, 53, 60, 63]. Lack of awareness [36, 45, 57]. Perceived barriers, and perceived severity [37, 45, 52]. Organizing information and education sessions on cervical cancer, and taking initiatives to reduce financial barriers [42, 60].
Healthcare Provider-Level Dedication and enthusiasm of the healthcare workers in advising and encouraging women. Adherence to the screening guidelines [48]. A lack of staff, insufficient on-the-job training, poor interpersonal care and counselling skills, and resistance to change [47, 62, 64]. Increased workloads [48, 55], and the prioritization of curative healthcare by health professionals [57]. Cost containment of skilled staff [36].
Institutional/ Organizational-Level Promotion of cervical cancer screening through various methods [45]. Supervisory visit [48]. A lack of resources, inappropriate use of funds, and competing priorities in ensuring comprehensive and sustainable HIV care [34, 51]. Trained staff turnover and a lack of regular supply of necessary equipment for cervical cancer screening, shortage of medication, protocols, guidelines, and high costs of preventive healthcare services [48, 55, 57]. Shortages of skilled health staff, high client loads, and territorialism among providers and managers. Weak supervision and management, the absence of integration indicators in monitoring and evaluation tools, and the lack of integrated care in performance appraisal, accreditation processes, and job descriptions have further been cited as obstacles, lack of infrastructure [36, 47, 57, 62]. Availability of more than one screening method [63] Strong advocacy and leadership [48].
Task shifting [63, 66].
Policy and Systems-Level Recognizing the importance of integration, international support for SRH-HIV integration, advocating for decentralization of services, implementing task-shifting protocols, and promoting the concept of "provider-initiated SRH." [47]. Absence of functional policy on preventive oncology, a lack of action from authorities, and insufficient funding [51]. Verticalized program structures, low funding and attention to SRH nationally, inadequate coordination between different levels of policy, territorial disputes over programs, absence of national guidelines on integration, and poor coordination between different healthcare sites [47]. Ensuring the implementation of provider-initiated SRH service [47]. Creating a coordinated network [36].

Ways/sites of integrating ccs into healthcare facilities

In most studies, CCS integration mainly occurred in HIV clinics [25, 3440]. A concurrent mixed design study conducted in South Africa showed that all key informants were in support of providing pap smears at HIV clinics because they saw a need for healthcare to be more comprehensive [41, 42].

However, some studies found that CCS was integrated into existing reproductive and sexual health [43] clinics, MCH-FP, well-baby clinics, maternal health clinics, Gynecology OPD, STD clinics, and this was feasible in resource-poor settings [4450]. Therefore, with adequate infrastructural support, training, mentoring, and program supervision, cervical cancer screening and treatment services can be effectively provided opportunistically [48].

Acceptance of integration of CCS service into healthcare facilities

The study in Kenya found that (87%) of women receiving HIV care and treatment received CCS services. Among the women screened, almost all (96%) accepted screening during the current visit, while the remaining women were screened during a first or second follow-up visit [64].

Similarly, a mixed approach study conducted in Uganda revealed that the majority of HIV-infected women (64.5%) accepted the integration of CCS into routine HIV care [25]. Studies also revealed that patients found integrated sexual and reproductive health (SRH)/Antiretroviral therapy(ART) services acceptable [40]. Another study from Kenya also showed that most of the women included in the study accepted CCS services integrated with the MCH-FP clinics [46].

Benefits of integration of CCS service into healthcare facilities

Integrating CCS services into existing clinics would provide multiple benefits, including access to more health services in a single visit and increased access to CCS for HIV-positive women. It would, indeed, be convenient to access all services under one roof. Integration was also seen as a way to prevent HIV-positive women from dying from cervical cancer and to reduce the frequency of visits to health facilities. It was also believed that integration would facilitate early detection and treatment of gynaecological diseases. Integration would enable healthcare providers to detect and treat cervical cancer lesions at an early stage, reducing mortality from the disease. Integration was also seen as a way to minimize loss to follow-up in the CCS program and to increase the availability of screening sites for women [25, 41, 61].

A study conducted in Kenya found that integrating cervical cancer screening into HIV clinics would be cost-saving from a societal perspective [41]. This is because integrating the screening program reduces overhead costs by utilizing existing resources [25]. Furthermore, the study showed that offering screening to women at the time of their HIV treatment greatly reduced costs associated with patient transportation and time [38, 42].

The perceived benefits include the convenience of receiving both HIV drugs and CCS on the same scheduled date, reducing disturbance and movement by seeking these services from different clinics. There is motivation to undergo CCS due to increased awareness and understanding of the importance of early detection and treatment of precancerous lesions. Compliance and adherence to annual screening are improved, and there are increased opportunities to undergo screening. Archiving screening results and HIV-related information in one file improves record keeping. Confidentiality of HIV patient information is maintained, reducing stigma from HIV-uninfected women and non-HIV health workers. There is also a preference to interact with HIV clinic health workers as they are familiar and trusted [25].

Disadvantage of integrated CCS services

Participants in the study expressed concerns regarding the limited health system capacity and the potential consequences of integrating HIV testing and cervical cancer screening. One worry was that women who fear HIV stigma might be deterred from getting screened for cervical cancer if the two are integrated. Additionally, participants raised concerns about the increased workload for healthcare providers and how it might impact efficiency and productivity. Integration could lead to a decrease in the number of women screened per day. Fragmentation of services also could be one of the disadvantages if the service is given in a separate room within the health facility [62].

Another concern that emerged from the study was the feeling of compassion towards the women. Some participants expressed empathy for those who test positive for both HIV and cervical cancer lesions, recognizing the heightened emotional distress they may experience. There was also a concern for the prolonged waiting time that women might face due to the integrated approach, as it could be seen as disrespectful or offensive to their needs [25, 38, 58]. Furthermore, participants felt compassion for women who might struggle to comprehend the integrated format and the concepts of both HIV and cervical cancer screening.

Barriers and facilitators to integrating cervical cancer screening into health institutions in LMICs

The barriers and facilitators were classified into four categories: individual/women, provider, organizational/system and policy levels.

Individual-level facilitators and barriers

Facilitators

Women were motivated to seek CCS services in family planning clinics due to the service’s high quality and comprehensive approach, conveniently providing access to multiple services [37, 45]. The willingness of women to undergo screening and receive treatment also played a significant role in facilitating the provision of these services within primary health centres [48]. Additionally, factors such as personal connections with those affected by cervical cancer, support from peers, experiencing suspicious symptoms, availability of free services, and the spread of information on CCS further contributed to the uptake of these services [37]. It was also highlighted that integrating CCS into HIV clinics is a cost-saving approach, compared to conducting non-integrated screening, when considering societal perspectives [42].

Besides, religion, high perceived risk of developing cervical cancer, and ever-screened for cervical cancer facilitated the acceptability of integration of cervical cancer screening into routine HIV care [25].

Barriers

Difficulties in persuading women to undergo CCS at the Gynaecology OPD after their ART Clinic appointment are evident. One major obstacle is their reluctance to visit another clinic after already devoting time to the ART Clinic and going through CD4 tests and documentation. To compound the issue, some women were uncertain about where to go and needed assistance from an attendant. Economic constraints and lack of social support to care for their children while they were at the clinic further hindered their willingness. Additionally, long waiting times deterred some women from seeking screening services [45, 60].

Another study also revealed numerous barriers faced by women, such as lack of awareness, poor knowledge and neglect, all of which hampered their willingness to undergo screening [45, 57]. Furthermore, discomfort in sharing their privacy with health workers who were aware of their HIV status, preferring to confide in health workers who had no prior knowledge of their condition, and apprehension about continued interactions with the same health workers for other HIV-related services presented challenges for integrating CCS into routine HIV care. Increased waiting times at the HIV clinic for CCS, as well as receiving both HIV and CCS services, were also highlighted as hindrances [25].

Other individual-level barriers identified in several studies were perceived patient barriers. Fear of the results and a cancer diagnosis further complicated the situation. Some women perceived CCS as a complex procedure, often referring to it as an "operation," fearing that manipulation of the fragile cervix could potentially cause cancer. Many had a misconception that only older or HIV-positive women were susceptible to cervical cancer and believed that the absence of signs or symptoms indicated a low risk of disease [37, 45, 64].

Healthcare provider-level facilitators and barriers

Facilitators

The key element in increasing women’s involvement in CCS was the dedication and enthusiasm of the healthcare workers in advising and encouraging eligible women to undergo screening. The Visual Inspection with Acetic Acid [65] providers adhered closely to the screening guidelines, evident through almost no refusal of treatment by the providers [48].

Barriers

While healthcare providers expressed their eagerness to incorporate cervical cancer screening services into the current system, they acknowledged several obstacles. These barriers included fragmented services, a lack of staff, insufficient on-the-job training, and limited patient education [62]. Providers also voiced concerns about increased workloads [48, 55] and the prioritization of curative healthcare by health professionals, which further hindered the integration of these services [57].

Institutional/Organizational-Level Service Facilitators and Barriers

Facilitators

The promotion of cervical cancer screening through various methods such as posters in waiting rooms, direct communication between healthcare providers and patients, and even community-based family planning methods distributors in rural and slum areas was one of the facilitators to increase acceptance of CCS by the women [45]. Additionally, organizing supervisory visits when there is a decrease in the number of women being screened in a specific clinic has consistently led to a higher uptake of CCS [48].

Barriers

Several studies have identified various barriers to integrating CCS into HIV care. These barriers include a lack of resources, inappropriate use of funds, and competing priorities in ensuring comprehensive and sustainable HIV care [34, 51]. Additionally, challenges such as trained staff turnover and a lack of regular supply of necessary equipment for CCS have been reported in some centres. Other identified barriers include a shortage of medication, protocols, guidelines, and high costs of preventive healthcare services [48, 55, 57].

Moreover, shortages of skilled health staff, high client loads, poor interpersonal care and counselling skills, judgmental attitudes, resistance to change, and territorialism among providers and managers have posed challenges. The orientation of HIV services to disease management and a lack of technical skills in sexual and reproductive health have also been identified as barriers. Ineffective training methodologies, weak supervision and management, the absence of integration indicators in monitoring and evaluation tools, and the lack of integrated care in performance appraisal, accreditation processes and job descriptions have further been cited as obstacles. Finally, infrastructure issues, such as limited access to water and electricity, inadequate space, and challenges in the referral system, have all been reported [47, 57, 62, 64].

Policy and systems-level facilitators and barriers

Facilitators

Some factors have been identified as policy-level facilitators for the integration of sexual and reproductive health (SRH) with HIV services. These include recognizing the importance of integration, receiving international support for SRH-HIV integration, advocating for decentralization of HIV services, implementing task-shifting protocols, and promoting the concept of "provider-initiated SRH." [47].

Barriers

The main reasons for the insufficient facilities and supplies for CCS in health centres were identified as the absence of a policy on preventive oncology, lack of action from authorities, and insufficient funding. Additionally, the lack of a functional policy on preventive oncology and the lack of action from authorities were noted as contributing factors [51]. Other issues included verticalized program structures in the Department of Health, low funding and attention to sexual and reproductive health nationally, inadequate coordination between different levels of policy, territorial disputes over programs, absence of national guidelines on integration, a dysfunctional referral system, and poor coordination between different healthcare sites [47].

Discussion

The findings of the scoping review on CCS integration into healthcare facilities in LMICs provide valuable insights into the ways, benefits, and acceptability of integrating CCS services into existing healthcare settings. The review identified the sites of integration, the acceptance of the integrated services by women, and the advantages and disadvantages associated with the integration.

One key finding is that most of the CCS integration occurred in HIV clinics, compared to the other sites available for opportunistic intervention. This is consistent with other findings which revealed the integration of cervical cancer screening in HIV clinic [65, 6770]. This finding highlights the potential benefits of integrating CCS services into HIV clinics, as it allows for streamlined care and ensures that HIV-positive women have access to CCS [65].

On the other hand, the review also revealed that CCS was found to be integrated into other healthcare settings such as reproductive and sexual health clinics, maternal health clinics, well-baby clinics, and gynecology OPDs. This finding is supported by similar studies which showed that CCS service was delivered opportunistically in the existing reproductive health services [7173]. This implies that with adequate infrastructural support, training, mentoring, and program supervision, CCS can be effectively provided opportunistically in these healthcare settings. This finding also suggests that integration of CCS services is feasible across various healthcare facilities in resource-poor settings. Consistent with reports which revealed that it is feasible for low-income countries to integrate cervical cancer prevention, screening and treatment into routine women’s health services [66, 70, 74, 75], such integration requires political will, cross-sectoral collaboration and planning, innovative partnerships and robust monitoring and evaluation [76].

The overall acceptance of integrated CCS services among women was found to be high in this review. This finding aligns with another similar study that reported a higher acceptance rate of opportunistic CCS among women [71]. It suggests that offering CCS services alongside other healthcare services can enhance acceptance and uptake among women, which is consistent with a scoping review that emphasized the importance of improving availability and accessibility of services to increase CCS uptake among women [77].

Integrated CCS services have numerous benefits, such as improving access to health services, preventing HIV-positive women from dying from cervical cancer, reducing the frequency of visits, facilitating early detection and treatment of gynaecological diseases, minimizing loss to follow-up, improving patient records and confidentiality, and being cost-saving. This is congruent with previously conducted study and recommendations of WHO’s cervical cancer elimination guideline for LMICs [9, 10, 65, 70].

During the scoping review, several barriers and facilitators to cervical cancer screening at various levels were also identified. At the individual/women level, several facilitators were identified. Women were motivated to seek cervical cancer screening services in family planning clinics due to the high quality and comprehensive approach offered. Factors such as availability of free services, and spreading information on cervical cancer screening further contributed to the uptake of these services. This is in agreement with similar studies that showed the availability of cervical cancer screening with family planning services and other primary care services facilitated CCS uptake [65, 78, 79]. It was also found that integrating cervical cancer screening into HIV clinics is a cost-saving approach which is in line with a previously conducted studies that revealed integrated CCS services is cost effective in terms of both direct and indirect service costs [65, 73, 76]. These facilitators highlight how providing high-quality services, comprehensive care, and involving individuals and communities in spreading awareness can increase the likelihood of women seeking screening services. This is also supported by another study which explored that involving different stakeholders to deal with integrated screening services would increase CCS uptake [65].

Nevertheless, there are several barriers at the individual/women level that hinder the uptake of cervical cancer screening. Lack of awareness, knowledge, long waiting times, discomfort in sharing privacy, fear of results and cancer diagnosis, perception of screening as a complex procedure, and misconceptions about risk factors further compounded the situation which is in agreement with previous studies [7, 7880]. Such barriers emphasize the importance of reducing structural and logistical challenges, improving education and awareness, addressing misconceptions, and implementing strategies to minimize waiting times.

At the healthcare provider level, healthcare providers’ adherence to screening guidelines, and their advice played a significant role in motivating and encouraging eligible women to undergo screening which is consistent with a study that identified encouraging women to have CCS increases the uptake [81]. However, there were also barriers reported by providers, such as fragmented services, a lack of staff, insufficient training, increased workloads, and prioritizing curative healthcare which is supported by other studies [65, 82, 83]. These barriers shed light on the need to ensure adequate staffing, resources, training, and institutional support for healthcare providers to integrate cervical cancer screening effectively.

At the institutional/organizational level, promoting screening through various methods and organizing supervisory visits were identified as facilitators, and found to increase acceptance of screening services which aligns with previous study [83]. However, several barriers to integration were also highlighted at this level, including resource constraints, competing priorities, turnover of staff, lack of necessary equipment, medication shortages, guideline adherence, and high costs of preventive care services. These barriers underline the need for increased investment, proper allocation of resources, strong management systems, and improved coordination between different levels of care provision [7, 78].

Finally, at the policy and systems level, recognizing the importance of integration, receiving international support, decentralized HIV services, task-shifting protocols, and provider-initiated sexual and reproductive health initiatives were identified as policy-level facilitators. This is in line with suggestions by the WHO’s cervical cancer elimination strategies for LMICs and another study [10, 70]. However, lack of policies, insufficient funding, absence of guidelines on integration, vertical program structures, territorial disputes, dysfunctional referral systems, and poor coordination between healthcare sites and policies were highlighted as barriers. This is in line with similar studies [7, 69, 78] These findings reveal the need for policy changes, improved coordination, and robust support for integrating cervical cancer screening with other healthcare services.

Implications for research

The review suggests that integrating CCS can improve access to screening and increase uptake among women. Further research is needed to understand the factors contributing to the acceptability of integrated services and develop strategies to enhance acceptance. The review also emphasizes the benefits of integrating CCS services and, challenges such as inadequate funding, staffing issues, lack of equipment and medication, poor infrastructure, and fragmented services pose barriers to integration. Overall, the findings highlight the barriers and facilitators influencing the integration of CCS in low- and middle-income countries (LMICs) and can guide future research in developing strategies to overcome these barriers and promote integration in LMIC health institutions.

Implications for policy makers

The study suggests that policy makers should utilize existing facilities and infrastructure for integrating cervical cancer screening services with reproductive and sexual health clinics, maternal health clinics, and well-baby clinics. They should also consider integrating screening with other healthcare services such as routine immunizations and family planning programs, as it can lead to cost savings. Additionally, policy makers need to address barriers related to the lack of policies on preventive oncology, insufficient funding, and limited coordination between healthcare sites. Overall, integrating cervical cancer screening is feasible and offers significant benefits, and policy makers should consider these findings to ensure successful integration and maximize women’s health.

Strength and limitations of the study

This is a novel scoping review that maps the literature on the integration of cervical cancer screening into health care facilities and its associated factors in LMICs. Besides, the study used five electronic databases containing peer-reviewed literature. This review is limited to publications in selected languages included in the review; this may bias some of the studies that maybe published in other language not included in this review. Inherent methodological limitation which the review included articles with poor quality assessment.

Conclusion

In summary, the findings of the scoping review demonstrated that CCS integration into healthcare facilities in LMICs is possible, beneficial, and generally well-accepted by women. Integration within existing clinics offers opportunities for improved access, early detection, and cost efficiencies. This review also highlighted various barriers and facilitators across individual/women, provider, organizational/system, and policy levels for the uptake and integration of cervical cancer screening services. By addressing these challenges, healthcare systems, policymakers, and service providers can work collaboratively to increase participation in screening programs, improve screening services, and ultimately reduce the burden of cervical cancer. Efforts should focus on enhancing access, awareness, affordability, reducing stigma, providing comprehensive care, ensuring sufficient resources and staffing, and establishing supportive policies to ensure successful integration, optimal patient outcomes, and effectively address the barriers identified in this review. Further research and implementation of integrated CCS services are necessary to prioritize women’s health in LMICs.

Supporting information

S1 Checklist. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist.

(DOCX)

pgph.0003183.s001.docx (56KB, docx)
S1 Table. Search terms based on the population, concept, and context (PCC) framework for MEDLINE.

(DOCX)

pgph.0003183.s002.docx (17KB, docx)
S2 Table. Joanna Briggs Institute (JBI) quality appraisal tool.

(DOCX)

pgph.0003183.s003.docx (29.5KB, docx)

Data Availability

All the relevant data are within the manuscript itself.

Funding Statement

This research was funded by the African Union Commission (AUC), Addis Ababa, Ethiopia through the Pan African University Life and Earth Science Institute (PAULESI), University of Ibadan, Nigeria (No. 1644 to RNK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.WHO. Cervical cancer [cited 29July 2023]. Available from: https://www.who.int/health-topics/cervical-cancer#tab=tab_1.
  • 2.Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197–e206. doi: 10.1016/S2214-109X(22)00501-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209–49. [DOI] [PubMed] [Google Scholar]
  • 4.WHO. Cervical Cancer Elimination Initiative. [cited 29 July 2023]. Available from: https://www.who.int/initiatives/cervical-cancer-elimination-initiative#cms.
  • 5.WHO. New recommendations for screening and treatment to prevent cervical cancer. [cited 29 July 2023]. Available from: https://www.who.int/news/item/06-07-2021-new-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer.
  • 6.Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS medicine. 2008;5(6):e132. doi: 10.1371/journal.pmed.0050132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Petersen Z, Jaca A, Ginindza T, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022;22(1):1–20, 486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.WHO. Fostering Resilience through Integrated Health Systems Strengthening. https://wwwwhoint/publications-detail-redirect/9789240033313. 2021.
  • 9.World Health Organization. A Global Strategy towards the Elimination of Cervical Cancer as a Public Health Problem, ISBN: 9789240014107. 2020. [Google Scholar]
  • 10.World Health Organization.Global strategy to accelerate the elimination of cervical cancer as a public health problem https://wwwwhoint/publications/i/item/9789240014107. 2020.
  • 11.PATH. PATH’s framework for health services integration. [cited 29 July 2023]. Available from: https://media.path.org/documents/GP_hsi_overview_bro.pdf.
  • 12.World Health Organization. INTEGRATED HEALTH SERVICES–WHAT AND WHY? https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_Apr2014/10_session_child_health_services/Apr2014_session10_integrated_health_services.pdf. Technical Brief No.1, 2008. 2008.
  • 13.Initiative I, editor Integration of sexual and reproductive health and HIV services. https://www.semanticscholar.org/paper/Integration-of-sexual-and-reproductive-health-and-Initiative/d57f6e78feb7e169d9ad4abb81b6b2c33613977c2015.
  • 14.Yimer NB, Mohammed MA, Solomon K, Tadese M, Grutzmacher S, Meikena HK, et al. Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis. Public Health. 2021;195:105–11. doi: 10.1016/j.puhe.2021.04.014 [DOI] [PubMed] [Google Scholar]
  • 15.Lemp JM, De Neve J-W, Bussmann H, Chen S, Manne-Goehler J, Theilmann M, et al. Lifetime prevalence of cervical cancer screening in 55 low-and middle-income countries. Jama. 2020;324(15):1532–42. doi: 10.1001/jama.2020.16244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Niyonsenga G, Gishoma D, Sego R, Uwayezu MG, Nikuze B, Fitch M, et al. Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali-Rwanda. Canadian Oncology Nursing Journal. 2021;31(3):266. doi: 10.5737/23688076313266274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gebreegziabher M, Asefa NG, Berhe S. Factors affecting the practices of cervical cancer screening among female nurses at public health institutions in Mekelle town, Northern Ethiopia, 2014: a cross-sectional study. Journal of Cancer Research. 2016;2016:1–7. [Google Scholar]
  • 18.Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical cancer and breast cancer screening uptake in low-income and middle-income countries: a systematic review. Asian Pac J Cancer Prev. 2017;18(7):1751. doi: 10.22034/APJCP.2017.18.7.1751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Amado G, Weldegebreal F, Birhanu S, Dessie Y. Cervical cancer screening practices and its associated factors among females of reproductive age in Durame town, Southern Ethiopia. PLoS ONE. 2022;17(12):e0279870. doi: 10.1371/journal.pone.0279870 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Arksey H O’Malley L. Scoping studies: towards a methodological framework. International journal of social research methodology. 2005;8(1):19–32. [Google Scholar]
  • 21.World Health Organization. Millennium Development Goals (MDGs) https://www.who.int/news-room/fact-sheets/detail/millennium-development-goals-(mdgs) [Internet]. 2018.
  • 22.Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. JBI Evidence Implementation. 2015;13(3):141–6. doi: 10.1097/XEB.0000000000000050 [DOI] [PubMed] [Google Scholar]
  • 23.Nada Hamadeh CVR, Eric Metreau & Shwetha Grace Eapen. WORLD BANK BLOGS [Internet]2022. Available from: https://blogs.worldbank.org/opendata/new-world-bank-country-classifications-income-level-2022-2023. [Google Scholar]
  • 24.The EndNote Team. EndNote. EndNote 20 ed. Philadelphia, PA: Clarivate; 2013. [Google Scholar]
  • 25.Ninsiima M, Nyabigambo A, Kagaayi J. Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda. BMC Health Services Research. 2023;23(1):333. doi: 10.1186/s12913-023-09326-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Udoh RH, Ansu-Mensah M, Tahiru M, Bawontuo V, Kuupiel D. Mapping evidence on women’s knowledge and practice of breast self-examination in sub-Saharan Africa: a scoping review protocol. Systematic Reviews. 2020;9(1):1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Pierz AJ, Randall TC, Castle PE, Adedimeji A, Ingabire C, Kubwimana G, et al. A scoping review: Facilitators and barriers of cervical cancer screening and early diagnosis of breast cancer in Sub-Saharan African health settings. Gynecologic oncology reports. 2020;33:100605. doi: 10.1016/j.gore.2020.100605 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of internal medicine. 2018;169(7):467–73. doi: 10.7326/M18-0850 [DOI] [PubMed] [Google Scholar]
  • 29.The Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for analytical cross sectional studies 2017. [cited 2022 22 June]. Available from: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Analytical_Cross_Sectional_Studies2017_0.pdf [Google Scholar]
  • 30.The Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for cohort studies 2017. [cited 2022 22 June]. Available from: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Cohort_Studies2017_0.pdf. [Google Scholar]
  • 31.The Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for prevalence studies 2017. [cited 2022 22 June]. Available from: https://jbi.global/sites/default/files/2020-08/Checklist_for_Prevalence_Studies. [Google Scholar]
  • 32.The Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for systematic reviews [cited 2022 22 June]. Available from: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Systematic_Reviews2017_0.pdf
  • 33.The Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for case control studies 2017. [cited 2022 22 June]. Available from: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Case_Control_Studies2017_0.pdf. [Google Scholar]
  • 34.Bekolo CE O’Bryan G, Tchago FE, Nangue C, Bekoule PS, Kollo B. Integrating cervical cancer screening with HIV care in Cameroon: comparative risk analysis of cervical disease in HIV-infected women receiving antiretroviral therapy to women in the general population. PLos one. 2016;11(2):e0149152. doi: 10.1371/journal.pone.0149152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pfaff C. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi. Malawi Medical Journal. 2018;30(3):211–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Coleman JS, Cespedes MS, Cu-Uvin S, Kosgei RJ, Maloba M, Anderson J, et al. An insight into cervical cancer screening and treatment capacity in sub-Saharan Africa. Journal of lower genital tract disease. 2016;20(1):31. doi: 10.1097/LGT.0000000000000165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sibanda E, Ruhode N, Madanhire C, Hatzold K, Cowan F. P17.15 Barriers and facilitators to uptake of cervical cancer screening among clients attending integrated hiv/sexual and reproductive health clinics in zimbabwe. Sexually Transmitted Infections. 2015;91(Suppl 2):A228–A9. [Google Scholar]
  • 38.Kumakech E, Andersson S, Wabinga H, Berggren V. Integration of HIV and cervical cancer screening perceptions of healthcare providers and policy makers in Uganda. BMC Public Health. 2014;14(1):1–12. doi: 10.1186/1471-2458-14-810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kumakech E, Andersson S, Wabinga H, Berggren V. Integration of HIV and cervical cancer screening perceptions and preferences of communities in Uganda. BMC women’s health. 2015;15(1):1–13. doi: 10.1186/s12905-015-0183-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Phiri S, Feldacker C, Chaweza T, Mlundira L, Tweya H, Speight C, et al. Integrating reproductive health services into HIV care: strategies for successful implementation in a low-resource HIV clinic in Lilongwe, Malawi. Journal of Family Planning and Reproductive Health Care. 2016;42(1):17–23. doi: 10.1136/jfprhc-2013-100816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ports KA, Haffejee F, Mosavel M, Rameshbabu A. Integrating cervical cancer prevention initiatives with HIV care in resource-constrained settings: a formative study in Durban, South Africa. Global public health. 2015;10(10):1238–51. doi: 10.1080/17441692.2015.1008021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Vodicka EL, Babigumira JB, Mann MR, Kosgei RJ, Lee F, Mugo NR, et al. Costs of integrating cervical cancer screening at an HIV clinic in Kenya. International Journal of Gynecology & Obstetrics. 2017;136(2):220–8. doi: 10.1002/ijgo.12025 [DOI] [PubMed] [Google Scholar]
  • 43.Ammoun R, Wami WM, Otieno P, Schultsz C, Kyobutungi C, Asiki G. Readiness of health facilities to deliver non-communicable diseases services in Kenya: a national cross-sectional survey. BMC Health Services Research. 2022;22(1):985. doi: 10.1186/s12913-022-08364-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Anderson J, Wysong M, Estep D, Besana G, Kibwana S, Varallo J, et al. Evaluation of cervical cancer screening programs in Cote d’Ivoire, Guyana, and Tanzania: Effect of HIV status. PloS one. 2015;10(9):e0139242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Claeys P, De Vuyst H, Mzenge G, Sande J, Dhondt V, Temmerman M. Integration of cervical screening in family planning clinics. International Journal of Gynecology & Obstetrics. 2003;81(1):103–8. doi: 10.1016/s0020-7292(03)00038-9 [DOI] [PubMed] [Google Scholar]
  • 46.Were E, Nyaberi Z, Buziba N. Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya. African health sciences. 2010;10(1). [PMC free article] [PubMed] [Google Scholar]
  • 47.Smit JA, Church K, Milford C, Harrison AD, Beksinska ME. Key informant perspectives on policy-and service-level challenges and opportunities for delivering integrated sexual and reproductive health and HIV care in South Africa. BMC Health Services Research. 2012;12:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Selmouni F, Sauvaget C, Dangbemey DP, Kpebo DDO, Dieng NM, Lucas E, et al. Lessons Learnt From Pilot Cervical Cancer Screening and Treatment Programmes Integrated to Routine Primary Health Care Services in Benin, Cote d’Ivoire, and Senegal. JCO Global Oncology. 2022;8:e2200051. doi: 10.1200/GO.22.00051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Roger E, Nwosu O. Diagnosing Cervical Dysplasia Using Visual Inspection of the Cervix with Acetic Acid in a Woman in Rural Haiti. International Journal of Environmental Research and Public Health. 2014;11(12):12304–11. doi: 10.3390/ijerph111212304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Rupani MP, Pawar AB, Bansal RK, Dalal M, Vachhani A, Parikh KD. Cross‐sectional study to assess the need to commence opportunistic screening of women for cervical cancer presenting with sexually transmitted disease in Western India. European Journal of Cancer Care. 2017;26(1):e12626. doi: 10.1111/ecc.12626 [DOI] [PubMed] [Google Scholar]
  • 51.Chawla PC, Chawla AK, Shrivastava R, Shrivastava A, Chaudhary S. Situation analysis of existing facilities for screening, treatment and prevention of cervical cancer in hospitals/primary health centers of Delhi-NCR region, India. Asian Pacific Journal of Cancer Prevention. 2014;15(13):5475–82. doi: 10.7314/apjcp.2014.15.13.5475 [DOI] [PubMed] [Google Scholar]
  • 52.Huchko MJ, Maloba M, Nakalembe M, Cohen CR. The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV‐positive women in low‐income countries. Journal of the International AIDS Society. 2015;18:20282. doi: 10.7448/IAS.18.6.20282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Odafe S, Torpey K, Khamofu H, Oladele E, Adedokun O, Chabikuli O, et al. Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Nigerian medical journal: journal of the Nigeria Medical Association. 2013;54(3):176. doi: 10.4103/0300-1652.114590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kulkarni PR, Rani H, Vimalambike MG, Ravishankar S. Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India. Asian Pac J Cancer Prev. 2013;14(9):5101–5. doi: 10.7314/apjcp.2013.14.9.5101 [DOI] [PubMed] [Google Scholar]
  • 55.Shiferaw N, Salvador-Davila G, Kassahun K, Brooks MI, Weldegebreal T, Tilahun Y, et al. The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia: successes and lessons learned. Global Health: Science and Practice. 2016;4(1):87–98. doi: 10.9745/GHSP-D-15-00325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Coleman JS, Cespedes MS, Cu-Uvin S, Kosgei RJ, Maloba M, Anderson J, et al. An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa. J Low Genit Tract Dis. 2016;20(1):31–7. doi: 10.1097/LGT.0000000000000165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wendimagegn NF, Bezuidenhout MC. Integrating promotive, preventive, and curative health care services at hospitals and health centers in Addis Ababa, Ethiopia. Journal of multidisciplinary healthcare. 2019:243–55. doi: 10.2147/JMDH.S193370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Milford C, Greener LR, Beksinska M, Greener R, Mabude Z, Smit J. Provider understandings of and attitudes towards integration: Implementing an HIV and sexual and reproductive health service integration model, South Africa. African Journal of AIDS Research. 2018;17(2):183–92. doi: 10.2989/16085906.2018.1478314 [DOI] [PubMed] [Google Scholar]
  • 59.Messersmith LJ, Semrau K, Anh TL, Trang NN, Hoa DM, Eifler K, et al. Women living with HIV in Vietnam: desire for children, use of sexual and reproductive health services, and advice from providers. Reprod Health Matters. 2012;20(39 Suppl):27–38. doi: 10.1016/S0968-8080(12)39640-7 [DOI] [PubMed] [Google Scholar]
  • 60.Boddu A, Bhatla N, Vashist S, Mathur S, Mahey R, Natarajan J, et al. Cervical Cancer Screening in HIV-Positive Women in India: Why, When and How? The Journal of Obstetrics and Gynecology of India. 2021;71(3):304–12. doi: 10.1007/s13224-020-01419-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Mpata PC, Nkosi ZZ. Experiences of cervical cancer screening in HIV-positive women in Zimbabwe. curationis. 2021;44(1):2184. doi: 10.4102/curationis.v44i1.2184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Diala PC, Randa M, Odhiambo J, Ganda G, Cohen CR, Mungo C. Barriers and Facilitators to Integrating Clinical Breast Examinations With Cervical Cancer Screening Programs in Outpatient Clinics in Western Kenya. JCO Global Oncology. 2021(7):1722–9. doi: 10.1200/GO.21.00272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Akpan E, Abinya N, Odhiambo E, Ekpo E. Determinants of an integrated cervical cancer screening services in primary healthcare: sharing lessons from Kisumu, Kenya. Journal of Public Health in Africa. 2023;14(4). doi: 10.4081/jphia.2023.1783 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Huchko MJ, Bukusi EA, Cohen CR. Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. International Journal of Gynecology & Obstetrics. 2011;114(2):106–10. doi: 10.1016/j.ijgo.2011.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.White HL, Meglioli A, Chowdhury R, Nuccio O. Integrating cervical cancer screening and preventive treatment with family planning and HIV‐related services. International Journal of Gynecology & Obstetrics. 2017;138:41–6. [DOI] [PubMed] [Google Scholar]
  • 66.Organization WH. Accelerating the elimination of cervical cancer as a global public health problem. World Health Organization. Regional Office for South-East Asia; 2019. [Google Scholar]
  • 67.Sigfrid L, Murphy G, Haldane V, Chuah FLH, Ong SE, Cervero-Liceras F, et al. Integrating cervical cancer with HIV healthcare services: A systematic review. PloS one. 2017;12(7):e0181156. doi: 10.1371/journal.pone.0181156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Duffy M, Ojikutu B, Andrian S, Sohng E, Minior T, Hirschhorn LR. Non‐communicable diseases and HIV care and treatment: models of integrated service delivery. Tropical Medicine & International Health. 2017;22(8):926–37. [DOI] [PubMed] [Google Scholar]
  • 69.Hope R, Kendall T, Langer A, Bärnighausen T. Health systems integration of sexual and reproductive health and HIV services in sub-Saharan Africa: a scoping study. J Acquir Immune Defic Syndr. 2014;67 Suppl 4(Suppl 4):S259–70. doi: 10.1097/QAI.0000000000000381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Davies N, Chersich M, Mullick S, Naidoo N, Makhoba N, Rees H, et al. Integrating Cervical Cancer Screening Into Safer Conception Services to Improve Women’s Health Outcomes: A Pilot Study at a Primary Care Clinic in South Africa. Sex Transm Dis. 2019;46(2):91–7. doi: 10.1097/OLQ.0000000000000914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Sancho-Garnier H, Khazraji YC, Cherif MH, Mahnane A, Hsairi M, El Shalakamy A, et al. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries. Vaccine. 2013;31:G51–G7. doi: 10.1016/j.vaccine.2012.06.046 [DOI] [PubMed] [Google Scholar]
  • 72.Deepika DK. A Study for early Diagnosis of Cin and Early Cancer Cervix in Kamla Raja Hospital, Gwalior—Visual Inspection of Cervix with Acetic Acid as Screening Test. Journal of Medical Science And clinical Research. 2019. [Google Scholar]
  • 73.Belhadj H, Rasanathan JJ, Denny L, Broutet N. Sexual and reproductive health and HIV services: Integrating HIV/AIDS and cervical cancer prevention and control. International Journal of Gynecology & Obstetrics. 2013;121:S29–S34. doi: 10.1016/j.ijgo.2013.02.002 [DOI] [PubMed] [Google Scholar]
  • 74.Binagwaho A, Ngabo F, Wagner CM, Mugeni C, Gatera M, Nutt CT, et al. Integration of comprehensive women’s health programmes into health systems: cervical cancer prevention, care and control in Rwanda. Bulletin of the World Health Organization. 2013;91:697–703. doi: 10.2471/BLT.12.116087 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Engels D, Hotez PJ, Ducker C, Gyapong M, Bustinduy AL, Secor WE, et al. Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer. Bull World Health Organ. 2020;98(9):615–24. doi: 10.2471/BLT.20.252270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Shetty MK, Garza JC. Well Woman Clinic Concept: An Integrated Approach for Screening and Early Diagnosis of Breast and Gynecological Cancers in Developing Countries. 2013. [Google Scholar]
  • 77.Lott BE, Trejo MJ, Baum C, McClelland DJ, Adsul P, Madhivanan P, et al. Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model. BMC Public Health. 2020;20(1):654. doi: 10.1186/s12889-020-08777-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Adedimeji A, Ajeh R, Pierz A, Nkeng R, Ndenkeh J Jr, Fuhngwa N, et al. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Women’s Health. 2021;21(1):74. doi: 10.1186/s12905-021-01211-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Mengesha MB, Chekole TT, Hidru HD. Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis. BMC Women’s Health. 2023;23(1):338. doi: 10.1186/s12905-023-02479-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Maar M, Burchell A, Little J, Ogilvie G, Severini A, Yang JM, et al. A qualitative study of provider perspectives of structural barriers to cervical cancer screening among first nations women. Women’s Health Issues. 2013;23(5):e319–e25. doi: 10.1016/j.whi.2013.06.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.O’Connor M, McSherry LA, Dombrowski SU, Francis JJ, Martin CM, O’Leary JJ, et al. Identifying ways to maximise cervical screening uptake: a qualitative study of GPs’ and practice nurses’ cervical cancer screening-related behaviours. HRB Open Res. 2021;4:44. doi: 10.12688/hrbopenres.13246.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Nkurunziza C, Ghebre R, Magriples U, Ntasumbumuyange D, Bazzett-Matabele L. Healthcare provider challenges to early detection of cervical cancer at primary healthcare level in Rwanda. Gynecologic Oncology Reports. 2021;37:100810. doi: 10.1016/j.gore.2021.100810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Lott BE, Halkiyo A, Kassa DW, Kebede T, Dedefo A, Ehiri J, et al. Health workers’ perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia. BMC Women’s Health. 2021;21(1):185. doi: 10.1186/s12905-021-01331-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0003183.r001

Decision Letter 0

Sadeep Shrestha

7 Feb 2024

PGPH-D-23-02587

Integration of cervical cancer screening into healthcare facilities in low-and middle-income countries: a scoping review

PLOS Global Public Health

Dear Dr. Kassa,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Sadeep Shrestha

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

- https://doi.org/10.1002/ijgo.12194

-https://doi.org/10.1186/s12913-023-09326-6

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

2. Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

a. State the initials, alongside each funding source, of each author to receive each grant.

b. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c. If any authors received a salary from any of your funders, please state which authors and which funders.

If you did not receive any funding for this study, please simply state: “The authors received no specific funding for this work.

2. Please provide separate figure files in .tif or .eps format only and remove any figures embedded in your manuscript file. Please also ensure all files are under our size limit of 10MB.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures 

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirement

3. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is nicely written and thorough review of the integration of cervical cancer screening into existing healthcare facilities in LMICs. As you will see in my review there are 2 major concerns: lack of clarity into the type of healthcare facility you are interested in (or is it all off them) and the manuscript is too long and repetitive.

You are interchanging and mixing “primary care facilities” and “healthcare facilities” which is causing confusion about what facilities you mean and are interested in. I think what you mean is: investigating CC screening into existing healthcare facilities that offer primary care services rather than offering CC screening as stand-alone services. This needs to be clarified early on (Introduction, line 63 would be a good place). Then be sure to choose and use the same language throughout (such as “healthcare facilities”). The abstract seem to imply you were comparing primary care facilities vs. all others. But Methods imply the type of facility does not matter.

Abstract:

Last sentence that “addressing the gaps could promote…integration..into primary care services”. Are you considering the various settings listed in the sentence prior and the results to be “primary care services”? If yes, please clarify earlier. If not, then rephrase this sentence because the earlier presented information indicates it is successful in many settings.

Introduction:

Last paragraph: you state there are several studies on CC screening uptake but there is still room for more comprehensive evidence. Please elaborate on WHY there is still a need for comprehensive evidence? As stated, there is no gap for you to address…

Methods:

Line 53-54: Is this references Figure 1? If so, mention that.

Results:

Overall the Results section while nicely written is too long and repetitive. It reads like a Discussion section. To cut: (1) you should only present facts directly from the studies reviewed and remove opinions/conclusions/narrative from yourself—this is done in the Discussion. For example: Line 227: after “highlighting” is your conclusion; (2) Cut language. Simply state the fact as it relates to the Subheading without additional descriptive language (Example: Line 329-330 you do not need. Jump right into the barriers. A suggestion to consider is using bullet points in each subheading to briefly state each relevant finding; and (3) consider combining subheads where information is repetitive or could go together.

I suggest cutting the Sections on Lines 212-225. The first is not needed and the second is already covered by your table which shows the types of facilities and you describe the facilities you found in the first 2 paragraphs. Everything here is repetitive.

Line 252-253: Please add the reference for this study.

Many of the results in each section are related to HIV clinics or HIV care, etc. There were many other clinics with CCS integration. Please make sure to mention those results. When you discuss HIV only clinics make sure the text is all together in that section. For example in Section: Benefits of Integration of CCS Service into Healthcare Facilities...Please consider re-arranging this section to flow better. You present several points specific to HIV clinics and then mix in statements related to other types of clinical outside of HIV. I suggest trying a paragraph on the benefits to integrating into HIV clinics and then another on the non-HIV specific information.

Numbers and statistics should be provided to support statements throughout. For example, Line 238 you say “most women included accepted…”. Please quantify “most” (i.e. 87% of women)

Discussion

This section is nicely written and what I expect from a Discussion. But with the current Results section it simply repeats. Making changes to the Results will help.

Reviewer #2: Summary

The study addresses a clearly important public health problem and explorers how the World Health Organization recommendations on integration of cervical cancer screening in health facilities are being implemented as well as facilitators and barriers. The goal of screening for cervical cancer is to find precancerous cervical cell changes when treatment can prevent cervical cancer from developing. The article is technically sound, has methodological rigor and is presented in an intelligible fashion.

Strengths

1. Use of multiple databases: Five electronic databases with peer-reviewed literature were used.

2. Scooping review conducted quality assessment of the journal articles.

3. the data supports most of the conclusions and is available in the manuscript

Weaknesses

1. While the author identifies the burden by region, the author fails to link the high burden of Cervical cancer in SSA to the persistent infection with the human papillomavirus (HPV), regional differences in the cervical cancer burden are related to inequalities in access to vaccination, screening and treatment services, risk factors including HIV prevalence, and social and economic determinants such as sex, gender biases and poverty and the fact that women living with HIV are 6 times more likely to develop cervical cancer compared to women without HIV.

2. While the scooping review conducted quality assessment of the journal articles, those very poorly on quality were also included (inherent weakness of scooping reviews)

3. In the discussion section, the authors could increase relevance of the discussion by including contemporary guidance such as and the recent WHO recommendations on HPV DNA testing. Linking study finding and the literature with the contemporary recommendations for screening could increase the utility of the research findings and implications for scale up

4. In line 464, there is a mention for further research needed to understand the factors contributing to the acceptability of integrated services and develop strategies to enhance acceptance. Most (all) of the studies in the scooping review considered VIA as the main screening method for cervical cancer. With the recommendation on integration of HPV testing as part of the screening algorithms, the study does not provide insights on how this could impact the conclusions. This could be another area of further research

Recommendation:

I recommend approval with minor changes.

Evidence and Examples

Major issues:

1. Beyond the targets for Cervical cancer control by 2030 and the 90-70-90 targets; it is advisable that the authors also provide recent literature of the screening recommendations by WHO on Cervical cancer screening using DNA PCR. In one or another, inclusion of the recent WHO recommendations of HPV DNA PCR testing could have an implication on the policy considerations in the conclusion of this study (lines 491-503)

2. While quality of the articles was assessed, the analysis includes results from some of the poor-quality articles. However, this inherent methodological limitation/observation is not included in the limitation of the study.

3. In the discussions, provide insight into regional variations of cervical cancer burden and screening practices and the findings in the scooping review.

Minor issues:

4. Line 99 “published from were retrieved the year 2000’ has a typographical error caused by sequencing of words. Please correct to “ published were retrieved from the year….

5. Lines 218 and 227 refer to most women. Kindly quantify the word most by providing the ratio or percentage in the brackets to validate the choice of the word most

6. Please clarify: Line 301/302 does not show integration, and yet presented as a barrier to uptake.

7. Please clarify: Line 330/331 refers to fragmented services while referring to integration. Kindly clarify

Other Points

-None

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE,

Attachment

Submitted filename: Reveiw report PLOSGPH-23-02587.pdf

pgph.0003183.s004.pdf (115KB, pdf)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0003183.r003

Decision Letter 1

Sadeep Shrestha

12 Apr 2024

Integration of cervical cancer screening into healthcare facilities in low-and middle-income countries: a scoping review

PGPH-D-23-02587R1

Dear Assistant professor Kassa,

We are pleased to inform you that your manuscript 'Integration of cervical cancer screening into healthcare facilities in low-and middle-income countries: a scoping review' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Sadeep Shrestha

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr Samson Haumba

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist.

    (DOCX)

    pgph.0003183.s001.docx (56KB, docx)
    S1 Table. Search terms based on the population, concept, and context (PCC) framework for MEDLINE.

    (DOCX)

    pgph.0003183.s002.docx (17KB, docx)
    S2 Table. Joanna Briggs Institute (JBI) quality appraisal tool.

    (DOCX)

    pgph.0003183.s003.docx (29.5KB, docx)
    Attachment

    Submitted filename: Reveiw report PLOSGPH-23-02587.pdf

    pgph.0003183.s004.pdf (115KB, pdf)
    Attachment

    Submitted filename: Rebuttal letter_21.docx

    pgph.0003183.s005.docx (27.6KB, docx)

    Data Availability Statement

    All the relevant data are within the manuscript itself.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES